Point72 Hong Kong Ltd Buys Shares of 9,910 Encompass Health Co. (NYSE:EHC)

Point72 Hong Kong Ltd bought a new stake in Encompass Health Co. (NYSE:EHC - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor bought 9,910 shares of the company's stock, valued at approximately $915,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in EHC. MassMutual Private Wealth & Trust FSB increased its stake in shares of Encompass Health by 87.8% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock worth $27,000 after purchasing an additional 137 shares during the period. Colonial Trust Co SC bought a new stake in shares of Encompass Health during the 4th quarter worth approximately $29,000. Transce3nd LLC acquired a new stake in shares of Encompass Health during the 4th quarter worth approximately $40,000. CBIZ Investment Advisory Services LLC increased its stake in shares of Encompass Health by 38.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock valued at $42,000 after purchasing an additional 127 shares during the last quarter. Finally, Tompkins Financial Corp acquired a new position in Encompass Health during the fourth quarter worth about $46,000. 97.25% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

EHC has been the subject of several recent research reports. Truist Financial reaffirmed a "buy" rating and issued a $135.00 price objective (up previously from $116.00) on shares of Encompass Health in a research note on Monday, April 28th. Barclays raised their price objective on shares of Encompass Health from $118.00 to $129.00 and gave the stock an "overweight" rating in a research report on Friday, April 25th. KeyCorp upped their price target on Encompass Health from $120.00 to $122.00 and gave the stock an "overweight" rating in a research note on Friday, April 25th. StockNews.com upgraded shares of Encompass Health from a "hold" rating to a "buy" rating in a report on Sunday, May 11th. Finally, UBS Group raised their target price on Encompass Health from $117.00 to $130.00 and gave the company a "buy" rating in a report on Monday, April 28th. Nine investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Encompass Health has a consensus rating of "Buy" and a consensus price target of $120.86.

Encompass Health Stock Performance

NYSE EHC traded up $0.28 during trading hours on Monday, reaching $121.15. 543,136 shares of the company were exchanged, compared to its average volume of 694,096. The business's 50 day simple moving average is $105.43 and its 200-day simple moving average is $100.74. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. Encompass Health Co. has a 1 year low of $82.74 and a 1 year high of $122.25. The stock has a market capitalization of $12.21 billion, a P/E ratio of 27.16, a P/E/G ratio of 2.31 and a beta of 0.91.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings results on Thursday, April 24th. The company reported $1.37 EPS for the quarter, beating analysts' consensus estimates of $1.19 by $0.18. The firm had revenue of $1.46 billion for the quarter, compared to analysts' expectations of $1.43 billion. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. The business's revenue for the quarter was up 10.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.12 EPS. On average, equities research analysts expect that Encompass Health Co. will post 4.8 earnings per share for the current year.

Encompass Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be given a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 0.56%. The ex-dividend date of this dividend is Tuesday, July 1st. Encompass Health's dividend payout ratio (DPR) is presently 14.05%.

Insiders Place Their Bets

In other Encompass Health news, EVP John Patrick Darby sold 10,000 shares of the firm's stock in a transaction dated Tuesday, April 29th. The stock was sold at an average price of $114.79, for a total value of $1,147,900.00. Following the sale, the executive vice president now owns 79,710 shares of the company's stock, valued at $9,149,910.90. This trade represents a 11.15% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Elissa Joy Charbonneau sold 4,279 shares of the business's stock in a transaction that occurred on Tuesday, May 6th. The stock was sold at an average price of $116.61, for a total transaction of $498,974.19. Following the completion of the transaction, the insider now directly owns 11,958 shares of the company's stock, valued at approximately $1,394,422.38. This represents a 26.35% decrease in their position. The disclosure for this sale can be found here. 2.00% of the stock is owned by corporate insiders.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.